LaNua Lands €6 Million for Life-Saving Blood Flow Tech
Deal News | Dec 13, 2024 | Enterprise Ireland
In a significant development in the medical technology sector, LaNua Medical has successfully raised €6 million to accelerate the development of its cutting-edge blood flow technology. This funding round was prominently backed by Enterprise Ireland, a leading state-backed venture capital firm. LaNua’s innovative technology focuses on improving patient outcomes and reducing healthcare costs, with potential applications across oncology and vascular diseases. The investment will enable LaNua to expedite its research and development efforts, aiming to bring its product to market swiftly and effectively.
Sectors
- Medical Technology
- Venture Capital
- Healthcare
Geography
- Ireland – Enterprise Ireland, a state-backed venture capital firm, is based in Ireland, indicating the primary geographical focus of the funding.
Industry
- Medical Technology – LaNua Medical is developing innovative blood flow technology, which places it within the medical technology sector focused on advancements in healthcare.
- Venture Capital – Enterprise Ireland's involvement in funding LaNua's development aligns with activities in the venture capital sector, which supports innovative tech startups with growth potential.
- Healthcare – The applications of LaNua's technology in oncology and vascular diseases are directly tied to the healthcare industry.
Financials
- €6 million – The investment amount secured by LaNua Medical from Enterprise Ireland to support the development of their blood flow technology.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| LaNua Medical | Target Company | Company | A medical technology company focused on developing innovative blood flow technology with applications in oncology and vascular diseases. |
| Enterprise Ireland | Investor | Company | A state-backed venture capital firm that provides funding and support to promising Irish startups. |